Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Rebound Therapy on Metabolic Outcomes and Quality of Life in Nigerian Patients With Type 2 Diabetes

NCT02701569 is registered in ClinicalTrials.gov with University of KwaZulu as lead sponsor.

NCT NCT02701569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02701569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Rebound Therapy on Metabolic Outcomes and Quality of Life in Nigerian Patients With Type 2 Diabetes
Lead sponsor
University of KwaZulu
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2014
Completion date
June 30, 2015
Enrollment
60 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes